The drug industry gathered in Madrid, Spain in October for CPhI.
The in-pharmatechnologist.com editorial team were there to track down all the breaking news and speak with the movers and shakers about the latest industry trends.
07-Nov-2012 - The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is largely unmet, according to Aesica.
25-Oct-2012 - CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
25-Oct-2012 - Ukraine hopes changes to import laws will help cut trial start-up time from six month to 45 days.
24-Oct-2012 - Penn Pharma is in talks with a number of “big players” over its upcoming high containment oral solid dose facility.
16-Oct-2012 - Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
15-Oct-2012 - Indian regulations should not change to suit Western GMP standards, according to the country’s Deputy Drug Controller.
15-Oct-2012 - BASF wants a share of the $1.5bn global market for drug grade omega-3 and expects the plant it is building to start shipping product early next year.
12-Oct-2012 - Albemarle says it is seeing a flight to quality as pharmaceutical fine chemical customers begin to return to western suppliers.
12-Oct-2012 - Novasep plans to build the ‘world’s largest’ chromatography-based API production plant with backing the French government, banks and gas firm Total.
10-Oct-2012 - Mutual recognition agreements between Western regulators would help ensure a safe API supply chain, according to the EFCG.
08-Oct-2012 - in-Pharmatechnologist.com is going to Madrid, Spain to meet API and excipient makers, Biopharma firms, processing tech developers and contract services organisation gathered for one of the drug industry's biggest trade shows....